Ningbo MedicalSystem Biotechnology Co Ltd (300439) — Capital Reinvestment Ratio
Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥48.96 Million) in capital expenditures (CN¥11.70 Million). See 300439 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ningbo MedicalSystem Biotechnology Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Ningbo MedicalSystem Biotechnology Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Ningbo MedicalSystem Biotechnology Co Lt stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.06x | CN¥397.81 Million | CN¥420.54 Million | ▲ +138.9% |
| 2023 | 0.44x | CN¥633.53 Million | CN¥280.37 Million | ▼ -17.6% |
| 2022 | 0.54x | CN¥564.67 Million | CN¥303.13 Million | ▲ +37.1% |
| 2021 | 0.39x | CN¥515.48 Million | CN¥201.82 Million | ▼ -6.9% |
| 2020 | 0.42x | CN¥912.07 Million | CN¥383.43 Million | ▼ -30.4% |
| 2019 | 0.60x | CN¥601.17 Million | CN¥363.20 Million | ▼ -43.3% |
| 2018 | 1.07x | CN¥418.80 Million | CN¥446.22 Million | ▼ -99.1% |
| 2016 | 119.24x | CN¥2.45 Million | CN¥292.59 Million | ▲ +22844.1% |
| 2015 | 0.52x | CN¥177.55 Million | CN¥92.27 Million | ▼ -17.8% |
| 2014 | 0.63x | CN¥116.51 Million | CN¥73.63 Million | ▼ -12.9% |
| 2013 | 0.73x | CN¥100.06 Million | CN¥72.61 Million | ▼ -40.0% |
| 2012 | 1.21x | CN¥46.78 Million | CN¥56.60 Million | ▲ +96.3% |
| 2011 | 0.62x | CN¥49.82 Million | CN¥30.71 Million | — |